Medical Oncology

Prof. Dr. Kayhan Ertürk

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
MelanomaSkin NeoplasmsCutaneous Malignant MelanomaLung NeoplasmsBreast NeoplasmsStomach NeoplasmsBrain NeoplasmsColorectal NeoplasmsDiabetes MellitusAnemiaAdenocarcinoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Melanoma 46 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Skin Neoplasms 44 publications
  • Cutaneous Malignant Melanoma 20 publications
  • Lung Neoplasms 16 publications
  • Breast Neoplasms 7 publications
  • Stomach Neoplasms 5 publications
  • Brain Neoplasms 3 publications
  • Colorectal Neoplasms 2 publications
  • Diabetes Mellitus 2 publications
  • Anemia 2 publications
  • Adenocarcinoma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workMelanomaExtracted from 46 publications · Model version —From source
  • Publications126 publicationsOpenAlexFrom source
  • ORCID0000-0001-5804-6800ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563495/doktorlarimiz.html#kayhan-erturksaglik.gov.tr

Scientific work

Publications on Melanoma

126 publications

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  2. Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s583473 PMID 42038552 Open-access full textSource: OpenAlex

  3. Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study

    Journal of Cancer, 2026

    DOI 10.7150/jca.138530 PMID 42807710 Open-access full textSource: OpenAlex

  4. Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

    Medicine, 2026

    DOI 10.1097/md.0000000000048711 PMID 42116366 Open-access full textSource: OpenAlex

  5. Prognostic value of PSMA PET–derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

    Cancer Imaging, 2026

    DOI 10.1186/s40644-026-01036-6 PMID 42063136 Open-access full textSource: OpenAlex

  6. Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study

    Breast Cancer Research, 2026

    DOI 10.1186/s13058-026-02312-w PMID 42210329 Open-access full textSource: OpenAlex

  7. Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16430-3 PMID 42351034 Open-access full textSource: OpenAlex

  8. Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61625-0 PMID 42457832 Open-access full textSource: OpenAlex

  9. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16667-y PMID 42693417 Open-access full textSource: OpenAlex

  10. Prognostic significance of pretreatment anemia in patients with advanced cutaneous melanoma

    Medical Research Journal, 2026

    DOI 10.5603/mrj.110156 Open-access full textSource: OpenAlex

View all 126 publications